CB2 modulator 1

CAS No. 666261-80-9

CB2 modulator 1 ( —— )

Catalog No. M26092 CAS No. 666261-80-9

CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 77 Get Quote
10MG 109 Get Quote
25MG 175 Get Quote
50MG 256 Get Quote
100MG 379 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CB2 modulator 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.
  • Description
    CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    S1P
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    666261-80-9
  • Formula Weight
    380.4
  • Molecular Formula
    C18H19F3N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC(F)(F)c1nc(Nc2ccccc2)ncc1C(=O)NCC1CCOCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hawkins JL, et al. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J Pharmacol Exp Ther. 2008 Sep;326(3):801-8.
molnova catalog
related products
  • AM-2232

    AM-2232 is a potent and unselective agonist of the cannabinoid receptors.

  • Anandamide

    Anandamide, an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55) in the central nervous system.

  • Revosimeline

    A novel potent cannabinoid receptor agonist.